Latest Market News

Page 139 of 1965
Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.
Ada Torres
Ada Torres
27 Apr 2026
The FDA has removed the postmarketing cardiac repolarization study requirement for Clinuvel's SCENESSE®, reflecting confidence in its long-term safety profile. This marks a regulatory milestone for the only approved treatment for erythropoietic protoporphyria in the US.
Ada Torres
Ada Torres
27 Apr 2026
Harvest Technology Group sharpened its international defence focus in Q1 2026, onboarding NATO and commercial clients to its Nodestream platform, progressing new video features, and appointing Jeff Sengelman as Executive Chair amid CEO transition.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Adisyn has confirmed a major graphene breakthrough compatible with semiconductor manufacturing and secured exclusive radar absorption rights, backed by a $14 million placement led by top institutional investors.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Diatreme Resources reported a $745,000 net loss for FY 2025 but strengthened its financial footing through asset sales and an IPO stake. The company’s Northern Silica Project and Cyclone Zircon Project showed significant technical progress, while a major Cape Flattery asset sale aims to streamline operations and unlock funding.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Klevo Rewards has made major strides in Q1 2026, unveiling an Australian dollar-backed stablecoin and securing SWIFT network access through Fly Wallet, boosting its global payments and rewards platform.
Claire Turing
Claire Turing
27 Apr 2026
Alliance Nickel is pursuing capital cost savings at its NiWest Nickel-Cobalt Project through vat leaching trials while reporting promising gold assay results from initial drilling at Australia United. A $4.15 million entitlement offer aims to fund these efforts amid ongoing offtake renegotiations with Stellantis.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Noxopharm’s Sofra™ oligonucleotides, delivered via InhaTarget’s inhalable lipid nanoparticles, achieved a significant reduction in lung inflammation in preclinical models, broadening Sofra’s therapeutic reach and delivery versatility.
Ada Torres
Ada Torres
27 Apr 2026
Megaport’s Latitude.sh has secured a $35.4 million three-year compute and storage deal, adding nearly $12 million in annual recurring revenue and underpinning the company’s growth in AI-driven infrastructure.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Fortuna Metals (ASX: FUN) has extended the rutile mineralisation footprint at its Mkanda Project in Malawi from 37km² to 53km², revealing high-grade cores and planning extensive drilling to underpin a maiden resource estimate in the second half of 2026.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Power Minerals has sealed its acquisition of the Morro do Ferro Rare Earths Project, a high-grade rare earth asset in Brazil, setting the stage for accelerated exploration and resource definition.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Oneview Healthcare boosted its cash reserves to €10.3 million by completing a significant capital raise and is progressing its AI-powered Care Assistant, Ovie, with pilot deployments planned for 2026.
Victor Sage
Victor Sage
27 Apr 2026